Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
26 |
|
Actual shortage: | 9 (35%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 17 (65%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
1 (4%) |
|
Overdue reports |
5 (56%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAT-DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226585 |
NAT-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226575 |
NAT-QUETIAPINE | 150MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226594 |
NAT-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2024-04-30 | 226579 |
NAT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2024-04-30 | 226582 |
NAT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-02-02 | 2024-05-10 | 218258 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0